While "Unknown Protein 2" remains unidentified, several functional proteins from C. revoluta have been studied:
If "Unknown Protein 2" were hypothetically under investigation, standard workflows would include:
Transcriptomic sequencing to isolate novel coding sequences.
Homology modeling using tools like BLAST or AlphaFold to predict structure and function.
Vector systems: Baculovirus (for eukaryotic post-translational modifications) or E. coli (for high-yield production) .
Enzymatic assays: Test catalytic activity using spectrophotometry or fluorometry.
Interaction studies: Co-immunoprecipitation (Co-IP) or yeast two-hybrid screens to identify binding partners .
Toxicity: Cycasin and β-methylamino-L-alanine (BMAA) complicate handling and extraction .
Genetic diversity: High rDNA polymorphism (~12% divergence) suggests complex genomic regulation .
Epigenetic modifications: Cytosine methylation in rDNA may influence protein expression and pseudogenization .
Proteomic profiling of C. revoluta tissues to catalog uncharacterized proteins.
CRISPR-Cas9 editing to knockout candidate genes and assess phenotypic impacts.
Structural biology: Cryo-EM or X-ray crystallography for unknown protein resolution.